| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Feb 20, 2025 | NeuroPace Inc | 10% Owner | Sell | 15.0 | -5,270,845 | -100.00% | ✗ | $49.5M |
| Oct 23, 2024 | Oct 28, 2024 | NeuroPace Inc | 10% Owner | Sell | 17.5 | -224,138 | -4.08% | ✗ | $1.2M |
| Oct 22, 2024 | Oct 24, 2024 | NeuroPace Inc | 10% Owner | Sell | 51.3 | -4,082 | -0.07% | ✗ | $24.9K |
| Oct 18, 2024 | Oct 22, 2024 | NeuroPace Inc | 10% Owner | Sell | 47.5 | -8,598 | -0.16% | ✗ | $53.4K |
| Oct 3, 2024 | Oct 18, 2024 | NeuroPace Inc | 10% Owner | Sell | 30.0 | -46,426 | -0.84% | ✗ | $303.4K |
| Aug 30, 2024 | Oct 3, 2024 | NeuroPace Inc | 10% Owner | Sell | 30.0 | -39,684 | -0.71% | ✗ | $274.7K |
| Nov 29, 2023 | Dec 1, 2023 | NeuroPace Inc | 10% Owner | Sell | 40.0 | -16,167 | -0.29% | ✗ | $141.9K |
| Nov 27, 2023 | Nov 29, 2023 | NeuroPace Inc | 10% Owner | Sell | 47.5 | -11,171 | -0.20% | ✗ | $99.1K |
| Jul 5, 2017 | Jul 5, 2017 | Rein Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +200,000 | 44.76% | ✗ | $3M |